• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

China New Enterprise Investment (CNEI)

Partners Group backs China baby products retailer in overseas M&A push

Partners Group has acquired a minority stake in Aiyingshi, a China-based maternity and baby products retailer, with a view to helping the company secure acquisitions and licensing agreements overseas.

  • Expansion
  • 23 November 2015
CNEI invests $15m in China private school operator

China New Enterprise Investment (CNEI) has led a $15 million round of funding for Guanghua Education Group, a China-based private school operator.

  • Expansion
  • 11 May 2015
CNEI ups takes in China’s Juxin International Leasing

China New Enterprise Investment (CNEI) has committed additional $16.3 million in Juxin International Leasing, increasing its stakes in the Chinese specialty leasing company to 19.08%.

  • Greater China
  • 08 January 2014
CNEI invests $25.4m in Chinese drug developer

China New Enterprise Investment (CNEI) has acquired a 17% stake in Fudan-Zhangjiang Bio-Pharmaceutical (FDZJ) for $25.4 million, becoming the second-largest shareholder in the Shanghai based bio-pharmaceutical firm.

  • Greater China
  • 05 November 2013
CNEI invests in Chinese drug developer

China New Enterprise Investment (CNEI) has committed $21 million to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (FDZJ), a Hong Kong-listed developer of drugs and diagnostic products.

  • Expansion
  • 21 March 2013
cfo-suit
China portfolio management: Accounting on the wild side

As private equity firms pay more attention to financial management and value-add in Chinese portfolio companies, recruiting a CFO with the right blend of skills and experience is vital – but difficult

  • Advisory
  • 29 August 2012
CNEI secures 9.4x return on partial exit from Liyuan Aluminum

China New Enterprise Investment (CNEI) has completed a partial exit from Jilin Liyuan Aluminum, one of the country’s leading aluminum extrusion product manufacturers, securing a 9.4x gross return.

  • Exits
  • 28 June 2012
VIDEO: CNEI's Xiaoyang Yu

Xiaoyang Yu, founding partner of growth-focused China New Enterprise Investment (CNEI), says that crowding and a lack of transparency are among the key challenges facing the private equity industry in China. She insists that, when it comes to due diligence,...

  • People
  • 25 October 2011
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013